Insight

Nizar Jacques Bahlis: The most comprehensive AI assisted individualized risk classifier in Multiple Myeloma

Photo taken from Nizar Jacques Bahlis/Twitter

Jan 14, 2024, 17:31

Nizar Jacques Bahlis: The most comprehensive AI assisted individualized risk classifier in Multiple Myeloma

Nizar Jacques Bahlis, Associate Professor at the Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, shared on X:

“‘Precognition’ in myeloma.

The most comprehensive AI assisted individualized risk classifier in MM Journal of Clinical Oncology by Francesco Maura, Sylvester Comprehensive Cancer Center. In addition to clinical features prediction model accounts for 20 genomic features including APOBEC.”

Read further.
Source: Nizar Jacques Bahlis/X

'Precognition' in myeloma cancer Francesco Maura Journal of Clinical Oncology Myeloma Nizar Jacques Bahlis OncoDaily Oncology Sylvester Comprehensive Cancer Center

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity